Abstract Details
|
PRESENTER |
No disclosure on file |
| John W. Rose, MD, FAAN (Imaging and Neurosciences Center) | The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care. |
| Elisabeth Meloche, MD (UniversityofMontreal) | No disclosure on file |
| Heather Gordish-Dressman | Heather Gordish-Dressman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AGADA Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Heather Gordish-Dressman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TRiNDS, LLC. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Statistical reviewer with TREAT-NMD TACT Committee. |
| Lauren Morgenroth (TRiNDS, LLC) | Ms. Morgenroth has received personal compensation for serving as an employee of TRiNDS. Ms. Morgenroth has stock in TRiNDS. |
| Robert T. Leshner, MD, FAAN (University of California San Diegp) | No disclosure on file |
| Susan Sparks | Susan Sparks has received personal compensation for serving as an employee of Sanofi. Susan Sparks has stock in Sanofi. |